GLP1RA could drugs lower high iron levels, study finds
GLP1RA agonists have been increasing in popularity for treating obesity and type 2 diabetes.
Sep 24, 2024
0
57
MeSH tree: C18.452.565.500
GLP1RA agonists have been increasing in popularity for treating obesity and type 2 diabetes.
Sep 24, 2024
0
57
A large-scale study has found that some people whose genetics are linked to the common iron overload condition hemochromatosis have substantially greater levels of liver, musculoskeletal and brain disease than previously ...
Mar 13, 2024
0
73
Liver doctors tell us that the general public's level of knowledge about the liver is surprisingly low. A study confirms this.
Dec 27, 2023
0
30
Fibrosis is associated with various chronic and life-threatening conditions, including pulmonary fibrosis, liver cirrhosis, kidney disease, and cardiovascular diseases, among others. These conditions collectively contribute ...
Dec 14, 2023
0
63
Genomic screening to identify hemochromatosis—a disorder that causes iron levels in the body to rise to dangerous levels—encourages people with the condition to seek treatment and ongoing management, a Geisinger has study ...
Oct 26, 2023
0
27
Scientists at Oregon Health and Science University have made a development that could lead to a greater understanding of Alzheimer's disease and vascular dementia: a new cause for the diseases that impact cognitive functioning.
Sep 21, 2023
1
101
A landmark discovery linking iron regulation to a rare blood cancer has led to clinical trials of a potential new treatment for patients with the incurable disease.
Apr 4, 2023
0
69
The severity of immune-mediated intestinal diseases such as graft-versus-host disease (GVHD) or inflammatory bowel diseases is known to be associated with alterations in the gut microbiome, but what leads to such disruption ...
Feb 2, 2023
0
62
Babies born prematurely who are fed formula may need iron supplementation like their breastfed counterparts, new research suggests.
Dec 13, 2022
0
38
High levels of certain intestinal bacteria, like Fusobacterium nucleatum, can promote tumor progression in patients with colorectal cancer. Now, Japanese scientists have revealed a unique mechanism through which excessive ...
Nov 10, 2022
0
87